No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch-Schönlein purpura.
暂无分享,去创建一个
J. Llorca | N. Ortego-Centeno | S. Castañeda | M. Gonzalez-gay | J. Martín | R. Blanco | F. Genre | R. López-Mejías | J. Miranda-filloy | T. Pina | B. Ubilla | A. Márquez | J. Rueda-Gotor | L. Sala-Icardo | R. Ochoa | B. Sevilla Pérez
[1] M. González-Gay,et al. Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. , 2011, Tissue antigens.
[2] L. Abasolo,et al. Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity , 2011, Rheumatology International.
[3] J. Borén,et al. A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population , 2008, Regulatory Peptides.
[4] W. Ollier,et al. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura , 2007 .
[5] Chien-Chang Lee,et al. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[6] T. Kishimoto,et al. Interleukin 6: from bench to bedside , 2006, Nature Clinical Practice Rheumatology.
[7] T. Ha. The role of tumor necrosis factor-α in Henoch-Schönlein purpura , 2004, Pediatric Nephrology.
[8] W. Ollier,et al. Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura. , 2004, The Journal of rheumatology.
[9] M. González-Gay,et al. Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. , 2002, Seminars in arthritis and rheumatism.
[10] W. Thomson,et al. Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura. , 2002, The Journal of rheumatology.
[11] M. González-Gay,et al. Epidemiology of the vasculitides. , 2001, Rheumatic diseases clinics of North America.
[12] J. Llorca,et al. Henoch-Schönlein Purpura in Children from Northwestern Spain: A 20-Year Epidemiologic and Clinical Study , 2001, Medicine.
[13] A. Pasternack,et al. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. , 2001, Rheumatology.
[14] Simon A. Jones,et al. The soluble interleukin 6 receptor: mechanisms of production and implications in disease , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] M. Gonzalez-gay,et al. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. , 1999, Medicine.
[16] V. Rodríguez-Valverde,et al. Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. , 1997, Arthritis and rheumatism.
[17] A. Bakkaloğlu,et al. The role of cytokines in Henoch Schonlein purpura. , 1997, Scandinavian journal of rheumatology.
[18] K. Tanikawa,et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. , 1995, Gut.
[19] G. Hunder,et al. Hypersensitivity vasculitis and Henoch-Schönlein purpura: a comparison between the 2 disorders. , 1992, The Journal of rheumatology.